
|Articles|July 1, 2007
- Volume 0 0
Update on Investigational Alzheimer's Drug
Author(s)Susan Farley
Advertisement
Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.
The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.
Articles in this issue
about 19 years ago
pharmacy TECHNOLOGY newsabout 19 years ago
pharmacy TECHNOLOGY productsabout 19 years ago
health-systems PRODUCT newsabout 19 years ago
generic times product newsabout 19 years ago
can you READ these Rxs?about 19 years ago
A closer look at new FDA actionsabout 19 years ago
can you READ these Rxs?about 19 years ago
compounding HOTLINEabout 19 years ago
Is There Science in Quality?about 19 years ago
Vaccines: Are You Protected?Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Connecting Care in a Changing Health System
2
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
3
Functional Cure of Hepatitis B Infections Among Patients Coinfected With HIV
4
White Bagging, Brown Bagging, and the Pharmacist Caught in the Middle
5










































































































